<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Establishing characteristics of Central <z:mp ids='MP_0008912'>nervous</z:mp> System (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is essential as <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease is associated with poor treatment outcome </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To document the characteristics of those cases of Burkitt's who had <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease at the time of presentation </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Prospective study of the clinical details of paediatric patients admitted and treated for Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> from January 1986 to December 1997 </plain></SENT>
<SENT sid="3" pm="."><plain>SETTING: Kenyatta National Hospital and seven provincial hospitals in Kenya </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURES: For every histologically proven Burkitt's case, the following were documented; Age, sex, geographical area (province in Kenya), complaints, physical findings, Cerebral Spinal Fluid (CSF) cytology results, Human <z:hpo ids='HP_0002721'>Immunodeficiencies</z:hpo> Virus screening test result and anatomical sites of the disease at the time of starting therapy </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A total of 1005 BL cases were studied and 961(95.6%) were aged between two and 15.4 years median age of six years consisting of males 587(61%) and females 374 (39%) while 44 (4.4%) cases between 16 and 57 years consisting of males 23 (52%) and females 21 (43%) </plain></SENT>
<SENT sid="6" pm="."><plain>The main complaints; <z:hpo ids='HP_0002315'>headache</z:hpo>, swelling mainly facial, <z:hpo ids='HP_0003270'>abdominal distension</z:hpo> and <z:hpo ids='HP_0000520'>proptosis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Peak duration at presentation 4 and 8 weeks, range 1 to 26 weeks </plain></SENT>
<SENT sid="8" pm="."><plain>Clinical evaluation demonstrated <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> in 5.6%, presenting as <z:hpo ids='HP_0002315'>headache</z:hpo>, blurring of vision and <z:hpo ids='HP_0002355'>difficulties in walking</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Physical examination noted para-<z:mp ids='MP_0000754'>paresis</z:mp>, <z:hpo ids='HP_0000602'>ophthalmoplegia</z:hpo> and <z:hpo ids='HP_0006824'>cranial nerve palsies</z:hpo>, while CSF demonstrated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells in 158 (18.4%) </plain></SENT>
<SENT sid="10" pm="."><plain>Overall <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> was found in 161 (16.8%), children and 39% adults </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were systemic and no primary <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> detected </plain></SENT>
<SENT sid="12" pm="."><plain>Peak age was 11 to 15 years for children </plain></SENT>
<SENT sid="13" pm="."><plain>Their provinces Eastern; 24.5%, Central 21.3%, and Rift Valley 23.4%, ethnic origins, Meru 29.5%, Kikuyu 23.9% and Kamba 23.7% </plain></SENT>
<SENT sid="14" pm="."><plain>The sites of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> for <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> cases were abdominal, combined sites, and skeletal while least in maxilla and jaw </plain></SENT>
<SENT sid="15" pm="."><plain>Seventy one per cent of adults had both CSF <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSION: <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> children cases were older, reduced M:F ratio; had skeletal/abdominal presentation and were from the Central province, Kikuyu tribe and a positive CSF cytology for malignant cells found in almost <z:hpo ids='HP_0000001'>all</z:hpo> cases with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease at presentation </plain></SENT>
<SENT sid="17" pm="."><plain>No primary <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> detected </plain></SENT>
<SENT sid="18" pm="."><plain>Geographically, cases were from mainly the highlands of Kenya </plain></SENT>
<SENT sid="19" pm="."><plain>High <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease in adults coincided with HIV positive serostatus </plain></SENT>
</text></document>